Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d518ee8d38e57a3334b9784761c8f0e0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2012-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df1699effe8a5a7aeae5a7211ab1b61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b5395ffef02d3bb9bcecece5805f11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c320807406970e5683fed6b283caf30 |
publicationDate |
2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140095074-A |
titleOfInvention |
Use of anti-alpha-synuclein antibodies to diagnose elevated levels of alpha-synuclein in the brain |
abstract |
The present invention relates to the use of an anti-alpha-synuclein antibody for the diagnosis of elevated levels of alpha -sinuclains in the brain. Specifically, the present invention relates to a method of assessing the level of a-synuclein in plasma or CSF following administration of an anti-α-synuclein antibody or antigen-binding fragment thereof to an examinee, Synuclein with sufficient activity to alter the net flux of [alpha] -sinuccine to the CSF in the brain. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020009482-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018128454-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-039807-B1 |
priorityDate |
2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |